Clinical Research, Pharma & Healthcare FinancingFoundation Medicine Adds MET Testing to IHC PortfolioBusiness WireMay 27, 2025August 1, 2025 by Business WireMay 27, 2025August 1, 20250156 Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC...